Randomized Trials of Cancer Drugs Are For Yesterday
RCTs are expensive, slow and yield frustratingly limited information. (Nature Outlook)
Randomized Trials of Cancer Drugs Are For Yesterday Read More »
RCTs are expensive, slow and yield frustratingly limited information. (Nature Outlook)
Randomized Trials of Cancer Drugs Are For Yesterday Read More »
Doctors today generally caution against framing malignancy as an enemy that one must personally defeat.
As a society, we can’t treat our way out of breast cancer.
It would be far too expensive. Although surgery, radiation, and
medical therapies for breast cancer have improved, the physical toxicity—and expense—of treating advanced-stage cancers would be too great.
High-Quality Mammography: A Step Forward for Women’s Health Read More »
No question about cancer is more contentious than its causes.
A Call For More Research On Cancer’s Environmental Triggers Read More »
By speaking up, advocates at the meeting have shifted the direction of breast cancer research. Some are alive, improbably, as
Commentary: How Patients Have Transformed A Medical Meeting About Breast Cancer Read More »